
|Articles|November 1, 2007
AMO & Zeiss in patent agreement
Advanced Medical Optics (AMO) has entered into a US patent license agreement with Carl Zeiss Meditec.
Advertisement
Advanced Medical Optics (AMO) has entered into a US patent license agreement with Carl Zeiss Meditec.
AMO's IntraLase subsidiary had granted a non-exclusive, royalty-bearing license to Carl Zeiss Meditec to use the IntraLase patent portfolio to provide femtosecond technology for corneal surgery. No other terms of the agreement have been made public.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
IGS 2026: Navigating MIGS and other modern glaucoma procedures
2
IGS 2026: The expanding role of artificial intelligence in ophthalmology
3
IGS 2026: Considering OCT in neuro-ophthalmology and neurological diseases
4
IGS 2026: Current clinical perspectives on optic disc drusen
5





























